About
Bridging biopharma executive perspective, clinical insights and strategic leadership
Dr. John “Chip” Scarlett brings a rare combination of scientific rigor, operational experience, and a distinct literary voice to an industry often dominated by jargon and groupthink.
His work focuses on the intersection of science, strategy and policy, with a particular emphasis on how drug development, regulatory, and commercial strategy married to effective organizational dynamics result in promising science becoming effective medicines.
Physician Scientist
Board-certified, Fellow of the American College of Physicians with a strong science background and expertise in clinical medicine.
Executive Leadership
Former Biotech CEO and Pharmaceutical executive with a track record in organizational strategy and development.
Strategic Advisor
Consulting for biotech companies, investors and boards on critical decision making.
Commentator
Independent voice on biopharma strategy with short and long-form analysis on scientific considerations, regulatory strategy, and critical development decisions. Comfortable with articulating unconventional perspectives on a broad array of topics.
Written commentary
Sculpting Fog Media
Sculpting Fog is an independent analysis on biopharma strategy, clinical development, and the business of turning science into medicine.
Consulting
Strategic insights for pivotal inflection points
High-stakes decisions where clinical and strategic clarity make the difference between breakthrough and breakdown.
Clinical Development Strategy
Strategy and trial design
Board Advisor
Strategic guidance
Due Diligence & Assessment
Clinical portfolio evaluation
Organizational Design
Talent strategy and org structure